Fibromyalgia pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Usama Talib (talk | contribs) |
||
| (42 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Fibromyalgia}} | {{Fibromyalgia}} | ||
{{CMG}} | {{CMG}} ; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
The exact cause of fibromyalgia is unknown. Multiple factors are believed to influence the development of fibromyalgia. Various hypotheses have been offered describing the pathogenesis of fibromyalgia. It is understood that [[Lyme disease]] may be a trigger of the symptoms of fibromyalgia. It is suggested that more than one clinical entity may be involved in the pathogenesis of fibromyalgia, ranging from a mild, [[idiopathic]] [[inflammation|inflammatory]] process to [[clinical depression]].<ref>http://www.springerlink.com/content/1271314042w8405g/ Mueller W, et al. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Jul 25</ref><ref>{{cite web | url = http://www.immunesupport.com/library/showarticle.cfm/ID/3579 | title = Late and Chronic Lyme Disease: Symptom Overlap with Chronic Fatigue Syndrome & Fibromyalgia}}</ref> | |||
==Pathophysiology== | ==Pathophysiology== | ||
The cause of fibromyalgia is unknown. | The exact cause of fibromyalgia is unknown. Multiple factors are believed to influence the development of fibromyalgia. Various hypotheses have been offered describing the pathogenesis of fibromyalgia. It is understood that [[Lyme disease]] may be a trigger of the symptoms of fibromyalgia. It is suggested that more than one clinical entity may be involved in the pathogenesis of fibromyalgia, ranging from a mild, [[idiopathic]] [[inflammation|inflammatory]] process to [[clinical depression]].<ref>http://www.springerlink.com/content/1271314042w8405g/ Mueller W, et al. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Jul 25</ref><ref>{{cite web | url = http://www.immunesupport.com/library/showarticle.cfm/ID/3579 | title = Late and Chronic Lyme Disease: Symptom Overlap with Chronic Fatigue Syndrome & Fibromyalgia}}</ref> | ||
=== Stress === | === Stress === | ||
*[[Stress (medicine)|Stress]] is a significant precipitating factor in the development of fibromyalgia.<ref>{{cite journal | author = Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L | title=The impact of life events in female patients with fibromyalgia and in female healthy controls. | journal=Eur Psychiatry |pages=33-41 | volume=15 | issue=5 | id=PMID 10954873 }}</ref><ref>{{cite journal | author= Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A, Amital H | title=Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? | journal=J Psychosom Res | pages=663-9 | volume=61 | issue=5 | id=PMID 17084145}}</ref><ref>{{cite journal | author= Raphael KG, Janal MN, Nayak S | title=Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. | journal=Pain Med.| pages=33-41 | volume=5 | issue=1 | id=PMID 14996235}}</ref> | |||
*A non-mainstream hypothesis is that fibromyalgia may be a [[psychosomatic illness]], described by John E. Sarno's "[[tension myositis syndrome]]." | |||
A non-mainstream hypothesis that fibromyalgia may be a [[psychosomatic illness]] | *Sarno believes many cases of [[chronic pain]] result from changes in the body caused by the mind's subconscious strategy of distracting painful or dangerous emotions. | ||
*Education, attitude change, (and in some cases, psychotherapy) are treatments proposed to stop the brain from using negative strategies to process painful emotions.<ref>{{cite book |last=Sarno|first=Dr. John E,|authorlink=John E. Sarno|title=The Mindbody Prescription: Healing the Body, Healing the Pain |year=1998 |isbn=0-446-67515-6 |pages=76-78}}</ref><ref>{{cite book |last=Sarno|first=Dr. John E. et al,| title=The Divided Mind: The Epidemic of Mindbody Disorders |year=2006 |isbn=0-06-085178-3 |pages=21-22,235-237,294-298}}</ref> | |||
*Robert G. Schwartz, MD, proposed an alternative view in which mind-body connections may play an important role in [[chronic]] disease (not just fibromyalgia). | |||
===Dopamine abnormality=== | ===Dopamine abnormality=== | ||
[[Dopamine]] is a [[catecholamine]] [[neurotransmitter]] | *[[Dopamine]] is a [[catecholamine]] [[neurotransmitter]] known for its role in the pathology of [[schizophrenia]], [[Parkinson's disease]], and [[addiction]]. | ||
*Fibromyalgia has been commonly referred to as a "stress-related disorder" due to its frequent onset and worsening of symptoms in the context of stressful events.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/16174484?ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum The role of life stress in fibromyalgia. [Curr Rheumatol Rep. 2005] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/12849719?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Chronic widespread pain and fibromyalgia: what we ...[Best Pract Res Clin Rheumatol. 2003] - PubMed Result<!-- Bot generated title -->]</ref> | |||
*It was therefore proposed that fibromyalgia may represent a condition characterized by low levels of central [[dopamine]] that likely results from a combination of genetic factors and exposure to environmental stressors, including psychosocial distress, [[physical trauma]], systemic [[viral infections]], or [[inflammation|inflammatory disorders]] (e.g. [[rheumatoid arthritis]], systemic [[lupus erythematosus]]).<ref>[http://www.ncbi.nlm.nih.gov/pubmed/14975515?ordinalpos=10&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Stress and dopamine: implications for the pathophy...[Med Hypotheses. 2004] - PubMed Result<!-- Bot generated title -->]</ref> | |||
*This conclusion was based on three key observations: | |||
**Fibromyalgia is associated with [[stress]]. | |||
**[[Chronic]] exposure to [[stress]] results in a disruption of [[dopamine]]-related [[neurotransmission]]. | |||
**[[Dopamine]] plays a critical role in modulating [[pain]] perception and central [[analgesia]] in areas such as the [[basal ganglia]] (including the [[nucleus accumbens]]), [[insular cortex]], [[anterior cingulate cortex]] [[thalamus]], [[periaqueductal gray]], and [[spinal cord]].<ref>[http://www.ncbi.nlm.nih.gov/pubmed/6314870?ordinalpos=113&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Dopamine-containing neurons in the spinal cord: an...[Ann Neurol. 1983] - PubMed Result<!-- Bot generated title -->]</ref> <ref>[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15975975 Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/9355111?ordinalpos=27&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum The effects of stress on central dopaminergic neur...[Neurochem Res. 1997] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/7715939?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum The role of the basal ganglia in nociception and p...[Pain. 1995] - PubMed Result<!-- Bot generated title -->]</ref> <ref>[http://www.ncbi.nlm.nih.gov/pubmed/10597883?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum The role of dopamine in the nucleus accumbens in a...[Life Sci. 1999] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.jneurosci.org/cgi/content/full/19/10/4169 Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception - Burkey et al. 19 (10): 4169 - Journal of Neuroscience<!-- Bot generated title -->]</ref> <ref>[http://www.ncbi.nlm.nih.gov/pubmed/15327817?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Dopamine and NMDA systems modulate long-term nocic...[Pain. 2004] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/1611515?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Neurophysiological, pharmacological and behavioral...[Brain Res. 1992] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/15275769?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Opiate anti-nociception is attenuated following le...[Pain. 2004] - PubMed Result<!-- Bot generated title -->]</ref> | |||
*As is the case with several [[neurotransmitters]], there is evidence for a role of [[dopamine]] in [[restless leg syndrome]], which is a common co-morbid condition in patients with fibromyalgia.<ref>[http://www.bmj.com/cgi/content/full/312/7042/1339 Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study - Yunus and Aldag 312 (7042): 1339 - BMJ<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/16816393?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Support for dopaminergic hypoactivity in restless ...[Brain. 2006] - PubMed Result<!-- Bot generated title -->]</ref> | |||
*Patients with [[Restless legs syndrome|restless leg syndrome]] have also been demonstrated to have [[hyperalgesia]] to static mechanical stimulation.<ref>[http://brain.oxfordjournals.org/cgi/content/full/127/4/773 Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome - Stiasny-Kolster et al. 127 (4): 773 - Brain<!-- Bot generated title -->]</ref> | |||
===Serotonin=== | ===Serotonin=== | ||
[[Serotonin]] is a [[neurotransmitter]] that is known to play a role in regulating sleep patterns, mood, feelings of well-being, concentration and descending inhibition of pain. | *[[Serotonin]] is a [[neurotransmitter]] that is known to play a role in regulating sleep patterns, [[mood]], feelings of well-being, concentration and descending inhibition of [[pain]]. | ||
*Accordingly, it has been hypothesized that the [[pathophysiology]] underlying the symptoms of fibromyalgia may be a dysregulation of [[serotonin]] [[metabolism]], which may explain (in part) many of the symptoms associated with the disorder. <ref>[http://www.ncbi.nlm.nih.gov/pubmed/1313504?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Platelet 3H-imipramine uptake receptor density and...[J Rheumatol. 1992] - PubMed Result<!-- Bot generated title -->]</ref><ref>[http://www.ncbi.nlm.nih.gov/pubmed/1374252?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Cerebrospinal fluid biogenic amine metabolites in ...[Arthritis Rheum. 1992] - PubMed Result<!-- Bot generated title -->]</ref> | |||
*However, [[selective serotonin reuptake inhibitors]] (SSRIs) have met with limited success in alleviating the symptoms of fibromyalgia. | |||
===Sleep disturbance=== | ===Sleep disturbance=== | ||
[[ | *The [[sleep disturbance]] hypothesis states that any event such as a [[trauma]] or illness that causes [[sleep disturbance]] and [[chronic pain]] may initiate fibromyalgia. | ||
*According to the hypothesis, [[Sleep|stage 4 sleep]] is critical for normal functioning of the [[nervous system]] because, in [[Sleep|stage 4 sleep]], certain neurochemical processes in the body "reset." | |||
The sleep disturbance/substance P hypothesis could explain "tender points" that are characteristic of fibromyalgia but which are otherwise enigmatic | *It is during that [[Sleep|stage 4 sleep]], [[pain]] causes the release of the [[neuropeptide]] [[substance P]] in the [[spinal cord]], which leads to amplification of [[pain]] and nerves to become more sensitive to [[pain]]. | ||
*If [[pain]] becomes [[chronic]] and systemic, this process can run out of control. | |||
*The sleep disturbance hypothesis holds that deep [[sleep]] is critical to reset the [[substance P]] mechanism and prevent this out-of-control effect. | |||
*The sleep disturbance/[[substance P]] hypothesis could explain "tender points" that are characteristic of fibromyalgia but which are otherwise enigmatic since their positions don't correspond to any particular set of nerve junctions or other obvious body structures. | |||
*The sleep disturbance hypothesis proposes that these locations are more sensitive because the [[sensory nerves]] that serve them are positioned in the spinal cord to be most strongly affected by [[substance P]]. | |||
*The sleep disturbance hypothesis could also explain some of more general neurological features of fibromyalgia since [[substance P]] is active in many other areas of the [[nervous system]]. | |||
*The sleep disturbance hypothesis could also explain a possible connection between fibromyalgia, [[chronic fatigue syndrome]] (CFS), and [[post-polio syndrome]] through damage to the ascending reticular activating system of the [[reticular formation]]. | |||
**This area of the brain, in addition to apparently controlling the sensation of [[fatigue]], is known to control sleep behaviors and is also believed to produce some [[neuropeptides]]. Thus, injury or imbalance in this area could cause both [[Chronic fatigue syndrome|CFS]] and sleep-related fibromyalgia. | |||
*[[Electroencephalography]] studies have shown that people with fibromyalgia lack [[slow-wave sleep]] and circumstances that interfere with [[Sleep|stage four sleep]] ([[pain]], [[depression]], [[serotonin]] deficiency, certain medications or [[anxiety]]) may cause or worsen the condition. | |||
===Human growth hormone=== | ===Human growth hormone=== | ||
An alternate hypothesis suggests that stress-induced problems in the [[hypothalamus]] may lead to reduced sleep and reduced production of [[human growth hormone]] (HGH) during [[slow-wave sleep]]. People with fibromyalgia tend to produce inadequate levels of | *An alternate hypothesis suggests that stress-induced problems in the [[hypothalamus]] may lead to reduced amounts of [[sleep]] and reduced production of [[human growth hormone]] (HGH) during [[slow-wave sleep]]. | ||
*People with fibromyalgia tend to produce inadequate levels of [[human growth hormone]]. | |||
This view is supported by the fact that | *Most patients with fibromyalgia with low [[Insulin-like growth factor-I|IGF-I]] levels failed to secrete [[HGH]] after stimulation with [[clonidine]] and [[L-dopa]]. | ||
*This view is supported by the fact that [[hormones]] under the direct or indirect control of [[HGH]], including [[IGF-1]], [[cortisol]], [[leptin|leptin,]] and [[neuropeptide Y]], are abnormal in people with fibromyalgia. | |||
*In addition, treatment with [[exogenous]] [[HGH]] or growth hormone [[secretagogue]] reduces fibromyalgia-related pain and restores [[slow-wave sleep]], but there is disagreement about the proposition.<ref name="pmid12672204">{{cite journal |vauthors=McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK |title=Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia |journal=J. Rheumatol. |volume=30 |issue=4 |pages=809–14 |year=2003 |pmid=12672204 |doi= |url=}}</ref><ref name="pmid10700334">{{cite journal |vauthors=Anderberg UM, Liu Z, Berglund L, Nyberg F |title=Elevated plasma levels of neuropeptide Y in female fibromyalgia patients |journal=Eur J Pain |volume=3 |issue=1 |pages=19–30 |year=1999 |pmid=10700334 |doi=10.1053/eujp.1998.0097 |url=}}</ref><ref name="pmid17224178">{{cite journal |vauthors=Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA |title=Growth hormone perturbations in fibromyalgia: a review |journal=Semin. Arthritis Rheum. |volume=36 |issue=6 |pages=357–79 |year=2007 |pmid=17224178 |doi=10.1016/j.semarthrit.2006.09.006 |url=}}</ref><ref>{{cite journal | last = Shuer | first = ML | title = Fibromyalgia: symptom constellation and potential therapeutic options | journal = Endocrine | volume = 22 | issue = 1 | pages = 67-76 | pmid = 14610300 }}</ref><ref name="pmid17289417">{{cite journal |vauthors=Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM |title=Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? |journal=Growth Horm. IGF Res. |volume=17 |issue=1 |pages=82–8 |year=2007 |pmid=17289417 |doi=10.1016/j.ghir.2006.12.006 |url=}}</ref><ref name="pmid9228141">{{cite journal |vauthors=Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM |title=Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia |journal=J. Rheumatol. |volume=24 |issue=7 |pages=1384–9 |year=1997 |pmid=9228141 |doi= |url=}}</ref> | |||
===Deposition disease=== | ===Deposition disease=== | ||
The | *The deposition hypothesis of fibromyalgia states that fibromyalgia is due to [[intracellular]] [[phosphate]] and [[calcium]] accumulations that eventually reach levels sufficient to impede the [[Adenosine triphosphate|ATP]] process. This may be caused by a [[kidney]] defect or missing [[enzyme]] that prevents the removal of excess [[phosphates]] from the [[bloodstream]]. | ||
*Proponents of this hypothesis suggest that fibromyalgia may be an inherited disorder and that [[phosphate]] buildup in cells is gradual but can be accelerated by trauma or illness. | |||
The phosphate build-up hypothesis explains many of the symptoms present in | *[[Calcium]] is required for the excess [[phosphate]] to enter the cells. The additional [[phosphate]] slows down the [[ATP]] process; however, the excess [[calcium]] stimulates the cell to continue producing [[ATP]]. | ||
*The [[phosphate]] build-up hypothesis explains many of the symptoms present in fibromyalgia and proposes an underlying cause. | |||
===Other hypotheses=== | ===Other hypotheses=== | ||
Other hypotheses | *Other hypotheses propose that fibromyalgia is caused by various [[toxin]]s from the patient's environment, [[virus|viral]] causes such as the [[Epstein-Barr Virus]], [[growth hormone]] deficiencies possibly related to an underlying (potentially [[autoimmune]]) disease affecting the [[hypothalamus]] gland, an aberrant immune response to [[intestinal bacteria]], [[neurotransmitter]] disruptions in the [[central nervous system]], and erosion of the protective chemical coating around [[sensory nerves]].<ref name="ClinExpDermatol2004-KendallSN">{{cite journal | author=Kendall SN | title=Remission of rosacea induced by reduction of gut transit time. | journal=Clin Exp dermatol.| pages=297-9 | volume=29 | issue=3 | pmid=15115515}}</ref><ref name="AnnRheumDis2004-PimentalM">{{cite journal | author=Pimental M, Wallace D, Hallegua D et .al | title=A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. | journal=Ann Rheum Dis.| pages=450-2 | volume=63 | issue=4 |pmid=15020342}}</ref> | ||
*A 2001 study suggested an increase in fibromyalgia among women with extracapsular silicone gel leakage from implants, compared to women whose implants were not broken or leaking outside the capsule.<ref name="Brown2001">{{cite journal | author=Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS | title=Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women | journal=J Rheumatol | year=2001 | pages=996-1003 | volume=28 | issue=5 | pmid=11361228}}</ref><ref>{{cite web |title=Study of Silicone Gel Breast Implant Rupture, Extracapsular Silicone, and Health Status in a Population of Women |url=http://www.fda.gov/cdrh/breastimplants/extracapstudy.html |date=May 29, 2001 |publisher=FDA}}</ref><ref>{{cite web |title=FDA Breast Implant Consumer Handbook 2004 |url=http://www.fda.gov/cdrh/breastimplants/handbook2004/diseases.html#1 |date=June 8, 2004 |publisher=FDA}}</ref><ref name="Lipworth">{{cite journal | author=Lipworth L, Tarone RE, McLaughlin JK.| title=Breast implants and fibromyalgia: a review of the epidemiological evidence.| journal=Ann Plast Surg. | year=2004 | pages=284-7| volume=52 | issue=3 |pmid=15156983}}</ref> | |||
*Another hypothesis states that patients suffer from [[vasomotor]] dysregulation leading to improper [[Blood vessel|vascular ]]flow and [[hypoperfusion]] (decreased blood flow to a given tissue or organ).<ref name="pmid17376601">{{cite journal |author=Katz DL, Greene L, Ali A, Faridi Z |title=The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation |journal=Med Hypotheses. |volume=(Epub ahead of print)|pmid=17376601 |doi=10.1016/j.mehy.2005.10.037}}</ref> | |||
==Associated Conditions== | |||
*Fibromyalgia always a [[comorbidity|comorbid]] disorder, occurring in combination with another disorder that likely triggers the fibromyalgia. | |||
*Other associated conditions include: | |||
**[[Gluten sensitivity]] | |||
**[[Irritable bowel syndrome]] | |||
***[[Irritable bowel syndrome]] is found at high frequency in patients with fibromyalgia and a large [[Celiac disease|celiac]] support group survey of adult celiacs revealed that 7% had fibromyalgia. | |||
**[[Chronic fatigue syndrome|Chronic fatigue]]<ref name="pmid16042909">{{cite journal | author = Frissora CL, Koch KL | title = Symptom overlap and comorbidity of irritable bowel syndrome with other conditions | journal = Current gastroenterology reports | volume = 7 | issue = 4 | pages = 264-71 | year = 2005 | pmid = 16042909 | doi = }}</ref> <ref name="pmid12741468">{{cite journal | author = Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E | title = Presentations of adult celiac disease in a nationwide patient support group | journal = Dig. Dis. Sci. | volume = 48 | issue = 4 | pages = 761-4 | year = 2003 | pmid = 12741468 | doi = }}</ref> | |||
== | == Genetics == | ||
By using self-reported "Chronic Widespread Pain" (CWP) as a surrogate marker for fibromyalgia, the [http://www.meb.ki.se/twinreg/index_en.html Swedish Twin Registry] found that a modest genetic contribution may exist:<ref name="PMID16646040">{{cite journal |author=Kato K, Sullivan P, Evengård B, Pedersen N |title=Importance of genetic influences on chronic widespread pain |journal=Arthritis Rheum. |volume=54 |issue=5 |pages=1682-6 |year=2006 | doi=10.1002/art.21798 |pmid=16646040}}</ref><ref name="PMID16908799">{{cite journal |author=Kato K, Sullivan P, Evengård B, Pedersen N |title=Chronic widespread pain and its comorbidities: a population-based study |journal=Arch. Intern. Med. |volume=166 |issue=15 |pages=1649-54 |year=2006 | url=http://archinte.ama-assn.org/cgi/content/full/166/15/1649 |pmid=16908799}}</ref> | |||
* [[Monozygotic twins]] with CWP have a 15% chance that their twin sibling has CWP. | |||
* [[Dizygotic twins]] with CWP have a 7% chance that their twin sibling has CWP. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 18:14, 14 August 2017
|
Fibromyalgia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibromyalgia pathophysiology On the Web |
|
American Roentgen Ray Society Images of Fibromyalgia pathophysiology |
|
Risk calculators and risk factors for Fibromyalgia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
The exact cause of fibromyalgia is unknown. Multiple factors are believed to influence the development of fibromyalgia. Various hypotheses have been offered describing the pathogenesis of fibromyalgia. It is understood that Lyme disease may be a trigger of the symptoms of fibromyalgia. It is suggested that more than one clinical entity may be involved in the pathogenesis of fibromyalgia, ranging from a mild, idiopathic inflammatory process to clinical depression.[1][2]
Pathophysiology
The exact cause of fibromyalgia is unknown. Multiple factors are believed to influence the development of fibromyalgia. Various hypotheses have been offered describing the pathogenesis of fibromyalgia. It is understood that Lyme disease may be a trigger of the symptoms of fibromyalgia. It is suggested that more than one clinical entity may be involved in the pathogenesis of fibromyalgia, ranging from a mild, idiopathic inflammatory process to clinical depression.[3][4]
Stress
- Stress is a significant precipitating factor in the development of fibromyalgia.[5][6][7]
- A non-mainstream hypothesis is that fibromyalgia may be a psychosomatic illness, described by John E. Sarno's "tension myositis syndrome."
- Sarno believes many cases of chronic pain result from changes in the body caused by the mind's subconscious strategy of distracting painful or dangerous emotions.
- Education, attitude change, (and in some cases, psychotherapy) are treatments proposed to stop the brain from using negative strategies to process painful emotions.[8][9]
- Robert G. Schwartz, MD, proposed an alternative view in which mind-body connections may play an important role in chronic disease (not just fibromyalgia).
Dopamine abnormality
- Dopamine is a catecholamine neurotransmitter known for its role in the pathology of schizophrenia, Parkinson's disease, and addiction.
- Fibromyalgia has been commonly referred to as a "stress-related disorder" due to its frequent onset and worsening of symptoms in the context of stressful events.[10][11]
- It was therefore proposed that fibromyalgia may represent a condition characterized by low levels of central dopamine that likely results from a combination of genetic factors and exposure to environmental stressors, including psychosocial distress, physical trauma, systemic viral infections, or inflammatory disorders (e.g. rheumatoid arthritis, systemic lupus erythematosus).[12]
- This conclusion was based on three key observations:
- Fibromyalgia is associated with stress.
- Chronic exposure to stress results in a disruption of dopamine-related neurotransmission.
- Dopamine plays a critical role in modulating pain perception and central analgesia in areas such as the basal ganglia (including the nucleus accumbens), insular cortex, anterior cingulate cortex thalamus, periaqueductal gray, and spinal cord.[13] [14][15][16] [17][18] [19][20][21]
- As is the case with several neurotransmitters, there is evidence for a role of dopamine in restless leg syndrome, which is a common co-morbid condition in patients with fibromyalgia.[22][23]
- Patients with restless leg syndrome have also been demonstrated to have hyperalgesia to static mechanical stimulation.[24]
Serotonin
- Serotonin is a neurotransmitter that is known to play a role in regulating sleep patterns, mood, feelings of well-being, concentration and descending inhibition of pain.
- Accordingly, it has been hypothesized that the pathophysiology underlying the symptoms of fibromyalgia may be a dysregulation of serotonin metabolism, which may explain (in part) many of the symptoms associated with the disorder. [25][26]
- However, selective serotonin reuptake inhibitors (SSRIs) have met with limited success in alleviating the symptoms of fibromyalgia.
Sleep disturbance
- The sleep disturbance hypothesis states that any event such as a trauma or illness that causes sleep disturbance and chronic pain may initiate fibromyalgia.
- According to the hypothesis, stage 4 sleep is critical for normal functioning of the nervous system because, in stage 4 sleep, certain neurochemical processes in the body "reset."
- It is during that stage 4 sleep, pain causes the release of the neuropeptide substance P in the spinal cord, which leads to amplification of pain and nerves to become more sensitive to pain.
- If pain becomes chronic and systemic, this process can run out of control.
- The sleep disturbance hypothesis holds that deep sleep is critical to reset the substance P mechanism and prevent this out-of-control effect.
- The sleep disturbance/substance P hypothesis could explain "tender points" that are characteristic of fibromyalgia but which are otherwise enigmatic since their positions don't correspond to any particular set of nerve junctions or other obvious body structures.
- The sleep disturbance hypothesis proposes that these locations are more sensitive because the sensory nerves that serve them are positioned in the spinal cord to be most strongly affected by substance P.
- The sleep disturbance hypothesis could also explain some of more general neurological features of fibromyalgia since substance P is active in many other areas of the nervous system.
- The sleep disturbance hypothesis could also explain a possible connection between fibromyalgia, chronic fatigue syndrome (CFS), and post-polio syndrome through damage to the ascending reticular activating system of the reticular formation.
- This area of the brain, in addition to apparently controlling the sensation of fatigue, is known to control sleep behaviors and is also believed to produce some neuropeptides. Thus, injury or imbalance in this area could cause both CFS and sleep-related fibromyalgia.
- Electroencephalography studies have shown that people with fibromyalgia lack slow-wave sleep and circumstances that interfere with stage four sleep (pain, depression, serotonin deficiency, certain medications or anxiety) may cause or worsen the condition.
Human growth hormone
- An alternate hypothesis suggests that stress-induced problems in the hypothalamus may lead to reduced amounts of sleep and reduced production of human growth hormone (HGH) during slow-wave sleep.
- People with fibromyalgia tend to produce inadequate levels of human growth hormone.
- Most patients with fibromyalgia with low IGF-I levels failed to secrete HGH after stimulation with clonidine and L-dopa.
- This view is supported by the fact that hormones under the direct or indirect control of HGH, including IGF-1, cortisol, leptin, and neuropeptide Y, are abnormal in people with fibromyalgia.
- In addition, treatment with exogenous HGH or growth hormone secretagogue reduces fibromyalgia-related pain and restores slow-wave sleep, but there is disagreement about the proposition.[27][28][29][30][31][32]
Deposition disease
- The deposition hypothesis of fibromyalgia states that fibromyalgia is due to intracellular phosphate and calcium accumulations that eventually reach levels sufficient to impede the ATP process. This may be caused by a kidney defect or missing enzyme that prevents the removal of excess phosphates from the bloodstream.
- Proponents of this hypothesis suggest that fibromyalgia may be an inherited disorder and that phosphate buildup in cells is gradual but can be accelerated by trauma or illness.
- Calcium is required for the excess phosphate to enter the cells. The additional phosphate slows down the ATP process; however, the excess calcium stimulates the cell to continue producing ATP.
- The phosphate build-up hypothesis explains many of the symptoms present in fibromyalgia and proposes an underlying cause.
Other hypotheses
- Other hypotheses propose that fibromyalgia is caused by various toxins from the patient's environment, viral causes such as the Epstein-Barr Virus, growth hormone deficiencies possibly related to an underlying (potentially autoimmune) disease affecting the hypothalamus gland, an aberrant immune response to intestinal bacteria, neurotransmitter disruptions in the central nervous system, and erosion of the protective chemical coating around sensory nerves.[33][34]
- A 2001 study suggested an increase in fibromyalgia among women with extracapsular silicone gel leakage from implants, compared to women whose implants were not broken or leaking outside the capsule.[35][36][37][38]
- Another hypothesis states that patients suffer from vasomotor dysregulation leading to improper vascular flow and hypoperfusion (decreased blood flow to a given tissue or organ).[39]
Associated Conditions
- Fibromyalgia always a comorbid disorder, occurring in combination with another disorder that likely triggers the fibromyalgia.
- Other associated conditions include:
- Gluten sensitivity
- Irritable bowel syndrome
- Irritable bowel syndrome is found at high frequency in patients with fibromyalgia and a large celiac support group survey of adult celiacs revealed that 7% had fibromyalgia.
- Chronic fatigue[40] [41]
Genetics
By using self-reported "Chronic Widespread Pain" (CWP) as a surrogate marker for fibromyalgia, the Swedish Twin Registry found that a modest genetic contribution may exist:[42][43]
- Monozygotic twins with CWP have a 15% chance that their twin sibling has CWP.
- Dizygotic twins with CWP have a 7% chance that their twin sibling has CWP.
References
- ↑ http://www.springerlink.com/content/1271314042w8405g/ Mueller W, et al. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Jul 25
- ↑ "Late and Chronic Lyme Disease: Symptom Overlap with Chronic Fatigue Syndrome & Fibromyalgia".
- ↑ http://www.springerlink.com/content/1271314042w8405g/ Mueller W, et al. The classification of fibromyalgia syndrome. Rheumatol Int. 2007 Jul 25
- ↑ "Late and Chronic Lyme Disease: Symptom Overlap with Chronic Fatigue Syndrome & Fibromyalgia".
- ↑ Anderberg UM, Marteinsdottir I, Theorell T, von Knorring L. "The impact of life events in female patients with fibromyalgia and in female healthy controls". Eur Psychiatry. 15 (5): 33–41. PMID 10954873.
- ↑ Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A, Amital H. "Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities?". J Psychosom Res. 61 (5): 663–9. PMID 17084145.
- ↑ Raphael KG, Janal MN, Nayak S. "Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women". Pain Med. 5 (1): 33–41. PMID 14996235.
- ↑ Sarno, Dr. John E, (1998). The Mindbody Prescription: Healing the Body, Healing the Pain. pp. 76–78. ISBN 0-446-67515-6.
- ↑ Sarno, Dr. John E. et al, (2006). The Divided Mind: The Epidemic of Mindbody Disorders. pp. 21–22, 235–237, 294–298. ISBN 0-06-085178-3.
- ↑ The role of life stress in fibromyalgia. [Curr Rheumatol Rep. 2005] - PubMed Result
- ↑ Chronic widespread pain and fibromyalgia: what we ...[Best Pract Res Clin Rheumatol. 2003] - PubMed Result
- ↑ Stress and dopamine: implications for the pathophy...[Med Hypotheses. 2004] - PubMed Result
- ↑ Dopamine-containing neurons in the spinal cord: an...[Ann Neurol. 1983] - PubMed Result
- ↑ Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors
- ↑ The effects of stress on central dopaminergic neur...[Neurochem Res. 1997] - PubMed Result
- ↑ The role of the basal ganglia in nociception and p...[Pain. 1995] - PubMed Result
- ↑ The role of dopamine in the nucleus accumbens in a...[Life Sci. 1999] - PubMed Result
- ↑ Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception - Burkey et al. 19 (10): 4169 - Journal of Neuroscience
- ↑ Dopamine and NMDA systems modulate long-term nocic...[Pain. 2004] - PubMed Result
- ↑ Neurophysiological, pharmacological and behavioral...[Brain Res. 1992] - PubMed Result
- ↑ Opiate anti-nociception is attenuated following le...[Pain. 2004] - PubMed Result
- ↑ Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study - Yunus and Aldag 312 (7042): 1339 - BMJ
- ↑ Support for dopaminergic hypoactivity in restless ...[Brain. 2006] - PubMed Result
- ↑ Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome - Stiasny-Kolster et al. 127 (4): 773 - Brain
- ↑ Platelet 3H-imipramine uptake receptor density and...[J Rheumatol. 1992] - PubMed Result
- ↑ Cerebrospinal fluid biogenic amine metabolites in ...[Arthritis Rheum. 1992] - PubMed Result
- ↑ McCall-Hosenfeld JS, Goldenberg DL, Hurwitz S, Adler GK (2003). "Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia". J. Rheumatol. 30 (4): 809–14. PMID 12672204.
- ↑ Anderberg UM, Liu Z, Berglund L, Nyberg F (1999). "Elevated plasma levels of neuropeptide Y in female fibromyalgia patients". Eur J Pain. 3 (1): 19–30. doi:10.1053/eujp.1998.0097. PMID 10700334.
- ↑ Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA (2007). "Growth hormone perturbations in fibromyalgia: a review". Semin. Arthritis Rheum. 36 (6): 357–79. doi:10.1016/j.semarthrit.2006.09.006. PMID 17224178.
- ↑ Shuer, ML. "Fibromyalgia: symptom constellation and potential therapeutic options". Endocrine. 22 (1): 67–76. PMID 14610300.
- ↑ Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM (2007). "Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?". Growth Horm. IGF Res. 17 (1): 82–8. doi:10.1016/j.ghir.2006.12.006. PMID 17289417.
- ↑ Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM (1997). "Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia". J. Rheumatol. 24 (7): 1384–9. PMID 9228141.
- ↑ Kendall SN. "Remission of rosacea induced by reduction of gut transit time". Clin Exp dermatol. 29 (3): 297–9. PMID 15115515.
- ↑ Pimental M, Wallace D, Hallegua D et .al. "A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing". Ann Rheum Dis. 63 (4): 450–2. PMID 15020342.
- ↑ Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS (2001). "Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women". J Rheumatol. 28 (5): 996–1003. PMID 11361228.
- ↑ "Study of Silicone Gel Breast Implant Rupture, Extracapsular Silicone, and Health Status in a Population of Women". FDA. May 29, 2001.
- ↑ "FDA Breast Implant Consumer Handbook 2004". FDA. June 8, 2004.
- ↑ Lipworth L, Tarone RE, McLaughlin JK. (2004). "Breast implants and fibromyalgia: a review of the epidemiological evidence". Ann Plast Surg. 52 (3): 284–7. PMID 15156983.
- ↑ Katz DL, Greene L, Ali A, Faridi Z. "The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation". Med Hypotheses. (Epub ahead of print). doi:10.1016/j.mehy.2005.10.037. PMID 17376601.
- ↑ Frissora CL, Koch KL (2005). "Symptom overlap and comorbidity of irritable bowel syndrome with other conditions". Current gastroenterology reports. 7 (4): 264–71. PMID 16042909.
- ↑ Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E (2003). "Presentations of adult celiac disease in a nationwide patient support group". Dig. Dis. Sci. 48 (4): 761–4. PMID 12741468.
- ↑ Kato K, Sullivan P, Evengård B, Pedersen N (2006). "Importance of genetic influences on chronic widespread pain". Arthritis Rheum. 54 (5): 1682–6. doi:10.1002/art.21798. PMID 16646040.
- ↑ Kato K, Sullivan P, Evengård B, Pedersen N (2006). "Chronic widespread pain and its comorbidities: a population-based study". Arch. Intern. Med. 166 (15): 1649–54. PMID 16908799.